Development of an intranasal vaccine against COVID-19
A needle-free vaccine against COVID-19 consisting of a viral vector expressing the SARS-CoV-2 spike protein
633 projects
Targeted vaccination against current and future corona viruses
COVAX aims to develop a vaccine against domains in the protein of SARS-CoV-2, to be used for current and future coronaviruses
Novel drugs to treat and prevent COVID-19
The PanCoroNed consortium will deliver novel drugs to treat COVID-19 and future corona outbreaks
Portable device for fast, reliable corona testing on the spot
Point-of care device for ultrasensitive coronavirus detection level using nanotechnology
Innovative Antibody Therapies Against COVID-19
The development of ultrapotent single-chain binding domains (SBDs) and antibodies to combat the novel coronavirus (SARS-CoV-2)
Rapid point of care tests to detect COVID-19
Rapid point of care tests to determine infection are urgently needed in the current COVID-19 pandemic, and will be designed and delivered in this project
Leiden joins forces to develop improved coronavirus vaccines
LUMC and two Leiden-based companies aim to develop broadly applicable vaccines against human coronaviruses
Electrocardiogram analysis for early detection of cardiovascular diseases in COVID-19 patients
Novel method to detect cardiac diseases in COVID-19 patients by using only standard 12-lead ECG
Antibodies against emerging zoonotic viruses
Novel strategies to combat emerging zoonotic viruses are urgently needed as is demonstrated by the emergence of SARS-coronavirus-2
Complex bacterial sugars as novel vaccine targets
Conserved cell wall polysaccharides as targets for broadly protective glycoconjugate vaccines against major Gram-positive pathogens